This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schwerdtle, R. F. Articles by Decker, H.-J. Search for Related Content PubMed PubMed Citation Articles by Schwerdtle, R. F. Articles by Decker, H.-J.

Loss of Heterozygosity Studies and Deletion Mapping Identify Two Putative Chromosome 14q Tumor Suppressor Loci in Renal Oncocytomas¹

Clinic of Hematology/Oncology/Pneumology [R. F. S., C. H., H-J. D.], Children's Hospital [A. W., B. Z.], and Department of Urology [W. B., R. H.], Johannes Gutenberg University, 55101 Mainz; and Institute of Pathology, University of Witten-Herdecke, 42283 Wuppertal [S. S.], Germany

Renal oncocytoma is considered to be a benign tumor that shares some phenotypic features with chromophobe renal cell carcinoma (RCC). Recently, we described high frequencies of allelic loss at 1p, 2p, 6p, 10p, 13q, 14q, 17p, and 21q, which correlate significantly with the chromophobe subtype of RCC. To investigate the genetic relationship between these two entities, we examined 12 oncocytomas for loss of heterozygosity (LOH) at these regions. In addition, we included markers for 3p, 5q, 7q, 11p, and 22q. The only chromosomal region showing similarly high frequencies of allelic loss for both subtypes was 14q. Therefore, a genetic relationship between renal oncocytoma and chromophobe RCC seems questionable. Eight of 12 oncocytomas (67%) showed LOH at 14q, a frequency that was significantly higher (P < 0.001, x² test) than the frequencies of LOH in all other regions. To define regions potentially harboring novel tumor suppressor genes, we performed multifluorescence microsatellite analysis with 13 markers spanning 14q. Interstitial deletions at different regions of 14q were detected, with the highest frequencies at D14S258 (14q23–24.3) and D14S292 (14q32.1–32.2). 14q LOH might be associated with advanced-stage RCCs or other tumors, but it does not seem to indicate progression in oncocytomas. Its role in pathogenesis of renal oncocytomas remains to be clarified. Here, we provide evidence for two distinct tumor suppressor gene loci at 14q in renal oncocytoma, which will be useful for further fine-mapping studies of these critical regions.

¹ This work was supported by the Deutsche Forschungsgemeinschaft (Grant De 356/3-2).

² To whom requests for reprints should be addressed, at the Clinic of Hematology/Oncology/Pneumology, Third Division of Medicine, Johannes Gutenberg University, Langenbeckstrasse 1, 55101 Mainz, Germany.

Received 8/18/97. Accepted 10/ 2/97.

This article has been cited by other articles:

				S. K. Khoo, K. Kahnoski, J. Sugimura, D. Petillo, J. Chen, K. Shockley, J. Ludlow, R. Knapp, S. Giraud, S. Richard, et al. Inactivation of BHD in Sporadic Renal Tumors Cancer Res., August 1, 2003; 63(15): 4583 - 4587. [Abstract] [Full Text] [PDF]

				D Kamnasaran and D W Cox Current status of human chromosome 14 J. Med. Genet., February 1, 2002; 39(2): 81 - 90. [Abstract] [Full Text] [PDF]

				S. Knuutila, Y. Aalto, K. Autio, A.-M. Bjorkqvist, W.'e. El-Rifai, S. Hemmer, T. Huhta, E. Kettunen, S. Kiuru-Kuhlefelt, M. L. Larramendy, et al. DNA Copy Number Losses in Human Neoplasms Am. J. Pathol., September 1, 1999; 155(3): 683 - 694. [Abstract] [Full Text] [PDF]